ArticleVeterinary surgery : VS2026
Long-term clinical outcome of maxillofacial fractures in horses: A retrospective study of 30 cases (2020-2024).
Article in Veterinary surgery : VS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess long-term outcome, complications, and return to function in horses with maxillofacial fractures. STUDY
designRetrospective observational study. ANIMALS: A total of 30 horses with skull fractures (2020-2024).
methodsClinical records were reviewed for signalment, fracture characteristics, imaging, treatment, and hospitalization. Long-term outcome was obtained via structured owner questionnaires addressing healing, complications, cosmetic appearance, and performance. Descriptive statistics were applied.
resultsA total of 29 of 30 horses received treatment (25 surgical, 4 conservative); one was euthanized. A total of 28 fractures were displaced (and 16 involved the frontal bone). Computed tomography was performed in 11 cases. Postoperative median hospitalization after surgery was 11 days (range: 4-57). Sinus lavage during surgery was performed in 22 of 25 surgically treated horses (84%). Median antimicrobial and non-steroidal anti-inflammatory drug (NSAID) administration lasted 15 (range: 4-26) and 8 days (range: 2-24), respectively. Complications included temporary nasal discharge in nine horses (31%) and wound infection in two horses (6.9%). At a median follow-up time of 830 days (range: 142-1754), 28 of the 29 treated horses (96.6%) were successfully recovered. Cosmetic defects were recorded in 22 animals (75.9%). Of the 26 horses with available performance follow-up, all returned to their previous level of use.
conclusionMaxillofacial fractures in horses were successfully managed in nearly all cases, with favorable long-term outcomes and minimal impact on performance, despite frequent cosmetic defects. CLINICAL SIGNIFICANCE: With timely treatment and supportive care, maxillofacial equine skull fractures carry an excellent prognosis for healing and return to use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.